✦ LIBER ✦

Reduction of myocardial ischemic injury following coronary intervention (The MC-1 to eliminate necrosis and damage trial)

✍ Scribed by David E Kandzari; Marino Labinaz; Warren J Cantor; Mina Madan; Dianne S Gallup; Vic Hasselblad; Diane Joseph; Andrew Allen; Cindy Green; Karl G Hidinger; Mitchell W Krucoff; Robert H Christenson; Robert A Harrington; James E Tcheng

Book ID: 113976897
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 84 KB
Volume: 92
Category: Article
ISSN: 0002-9149
DOI: 10.1016/s0002-9149(03)00818-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A randomized, double-blind, placebo-cont

A randomized, double-blind, placebo-controlled, multicenter study to evaluate the cardioprotective effects of MC-1 in patients undergoing high-risk coronary artery bypass graft surgery: MC-1 to Eliminate Necrosis and Damage in Coronary Artery Bypass Graft Surgery Trial (MEND-CABG) II—study design and rationale

✍ Rajendra H. Mehta; John H. Alexander; Robert Emery; Stephen J. Ellis; Vic Hassel 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 209 KB

Japan working groups of acute myocardial

Japan working groups of acute myocardial infarction for the reduction of necrotic damage (JWIND) by ANP or nicorandil), a large-scale trial using atrial natriuretic peptide or nicorandil as an adjunct to percutaneous coronary intervention for ST-segment elevation acute myocardial infarction

📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 42 KB